Celltrion
068270.KS
#755
Rank
NZ$54.17 B
Marketcap
NZ$247.65
Share price
1.40%
Change (1 day)
19.65%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): NZ$3.22

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$3.16. In 2024 the company made an earnings per share (EPS) of NZ$2.24 a decrease over its 2023 EPS that were of NZ$4.44.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$3.2243.95%
2024NZ$2.24-49.57%
2023NZ$4.44-2.08%
2022NZ$4.53-11.72%
2021NZ$5.142.03%
2020NZ$5.0382.8%
2019NZ$2.7518.31%
2018NZ$2.33-36.33%
2017NZ$3.66161.25%
2016NZ$1.402.86%
2015NZ$1.3617.84%
2014NZ$1.155.87%
2013NZ$1.09-70.85%
2012NZ$3.74134.09%
2011NZ$1.6043.59%
2010NZ$1.1174.49%
2009NZ$0.64317.8%
2008NZ$0.15-71.7%
2007NZ$0.54